跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VI-16
首页
药物
VI-16
VI-16
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for identifying lactobacillus helveticus Zhedu LBH-VI strain and application
申请人: TIBET ANQI BIOTECHNOLOGY CO LTD
优先权: 2024
CN
Type VI myosin related antigen epitope peptide and application thereof
申请人: XUANWU HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2026
CN
METHOD FOR BIOSYNTHESIS OF HUMAN STRUCTURAL MATERIAL TYPE VI COLLAGEN
申请人: SHANXI JINBO BIO PHARMACEUTICAL CO LTD
优先权: 2023
CN
WO
5 件公开
COSMETIC COMPOSITIONS CONTAINING MULBERRY EXTRACT AND RETINOIDS
申请人: UNILEVER PLC
优先权: 1999
CN
WO
2 件公开
Fungicidal mixtures
申请人: BASF AG
优先权: 2002
US
METHOD FOR FORMING A DISPERSION COMPRISING DROPS AND ASSOCIATED DEVICE
申请人: CAPSUM
优先权: 2022
CN
WO
2 件公开
ADAMANTANE DERIVATIVE, EPOXY RESIN, AND OPTICAL ELECTRONIC MEMBER USING RESIN COMPOSITION COMPRISING THEM
申请人: IDEMITSU KOSAN CO
优先权: 2005
CN
US
2 件公开
Insulin-oligomer conjugates, formulations and uses thereof
申请人: BIOCON LTD
优先权: 2005
US
2 件公开
药物
反馈